CurrentRheuma coverage · page 12 of 23

RMD Open

Briefs 441–480 of 899 CurrentRheuma has covered from this journal, newest publication first

Latest from RMD Open

All coverage, newest first

RMD Open12 Nov 2024
Is rheumatoid arthritis always preceded by a symptomatic at-risk phase of arthralgia?
Cohort studyRA
RMD Open12 Nov 2024
Routine radiographs of hands and feet do not have diagnostic or prognostic value in patients with clinically suspect arthralgia: a large longitudinal study
Cohort studyRA
RMD Open7 Nov 2024
Chronic kidney disease in patients with psoriatic arthritis: a cohort study
Cohort studySpondyloarthritis & PsA
RMD Open7 Nov 2024
Remission versus low disease activity as treatment targets in rheumatoid arthritis: how to strike the right balance between too strict and too lenient targets? A meta-epidemiological study of individual patient data
Meta-analysisRA
RMD Open2 Nov 2024
Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis: results from nine European rheumatology registries
Cohort studySpondyloarthritis & PsA
RMD Open30 Oct 2024
Association between musculoskeletal sonographic features and response to treatment in patients with psoriatic arthritis
Cohort studySpondyloarthritis & PsA
RMD Open28 Oct 2024
Value of the central sensitisation inventory in patients with axial spondyloarthritis
Cross-sectional studySpondyloarthritis & PsA
RMD Open26 Oct 2024
Baseline and 2-year differences in spinal symptoms and spinal and hip mobility in early axial spondyloarthritis and non-axial spondyloarthritis chronic back pain patients
Cohort studySpondyloarthritis & PsA
RMD Open26 Oct 2024
Disease response in rheumatoid arthritis across four biologic therapies associates with improvement in paraoxonase-1 activity and oxylipins
Cohort studyRA
RMD Open24 Oct 2024
Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study
Research articleRA
RMD Open23 Oct 2024
Depression, anxiety and cognitive function in persons with inflammatory rheumatic diseases: cross-sectional results from the German National Cohort (NAKO)
Cross-sectional studyAcross diseases
RMD Open23 Oct 2024
The mSQUASH is a feasible and valid measurement tool to uniformly assess daily physical activity in patients with rheumatic diseases
Diagnostic or prognostic studyAcross diseases
RMD Open22 Oct 2024
Characterisation of myeloid cells in circulation and synovial fluid of patients with psoriatic arthritis
Mechanistic studySpondyloarthritis & PsA
RMD Open22 Oct 2024
Comparing outcomes of patients with early active rheumatoid arthritis initially treated on an inpatient or outpatient basis: a posthoc analysis of the CORRA trial
Secondary analysisRA
RMD Open22 Oct 2024
Digital biomarkers for psoriatic arthritis: a qualitative focus group study on patient-perceived opportunities and barriers
Research articleSpondyloarthritis & PsA
RMD Open18 Oct 2024
Comorbidity burden on mortality in patients with systemic sclerosis
Cohort studySystemic sclerosis
RMD Open18 Oct 2024
The effect of rituximab on patient reported outcomes in the preclinical phase of rheumatoid arthritis: 2 year data from the PRAIRI study
Secondary analysisRA
RMD Open18 Oct 2024
Combining patient-reported outcome measures to screen for active disease in rheumatoid arthritis and psoriatic arthritis
Diagnostic or prognostic studyRA
RMD Open18 Oct 2024
Efficacy and safety of CT-P47 versus reference tocilizumab: 32-week results of a randomised, active-controlled, double-blind, phase III study in patients with rheumatoid arthritis, including 8 weeks of switching data from reference tocilizumab to CT-P47
Randomized controlled trialRA
RMD Open8 Oct 2024
Cardiovascular risk according to genetic predisposition to gout, lifestyle and metabolic health across prospective European and Korean cohorts
Cohort studyGout & crystals
RMD Open7 Oct 2024
Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMID
Mechanistic studyRA
RMD Open2 Oct 2024
Forefoot inflammation in recent-onset ACPA-positive and ACPA-negative RA: clinically similar, but different in underlying inflamed tissues
Cross-sectional studyRA
RMD Open2 Oct 2024
Development of a web-based ecological momentary assessment tool to measure day-to-day variability of the symptoms in patients with Sjögren’s disease
Cohort studySjögren's & overlap
RMD Open2 Oct 2024
Systematic screening for multimorbidities in patients with inflammatory rheumatic diseases enhanced preventive medication use and reduced hospitalisations: an exposed-non-exposed study
Cohort studyAcross diseases
RMD Open30 Sep 2024
Change in different classes of chronic back pain suspicious of axial spondyloarthritis: a latent transition analysis of the SPACE cohort
Cohort studySpondyloarthritis & PsA
RMD Open24 Sep 2024
Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies
Mechanistic studyVasculitis & PMR
RMD Open23 Sep 2024
Long versus short-term opioid therapy for fibromyalgia syndrome and risk of depression, sleep disorders and suicidal ideation: a population-based, propensity-weighted cohort study
Cohort studyFibromyalgia & pain
RMD Open23 Sep 2024
Bimekizumab provided rapid improvements in patient-reported symptoms and health-related quality of life in patients with active psoriatic arthritis: pooled 16-week results from two phase 3 studies
Meta-analysisSpondyloarthritis & PsA
RMD Open23 Sep 2024
Frailty is independently associated with subclinical cardiovascular disease in patients with systemic lupus erythematosus
Cross-sectional studyLupus & APS
RMD Open23 Sep 2024
Predicting the risk of cardiovascular and cerebrovascular event in systemic lupus erythematosus: a Chinese SLE treatment and research group study XXVI
Diagnostic or prognostic studyLupus & APS
RMD Open20 Sep 2024
Autoantibodies, cutaneous subset and immunosuppressants contribute to the cancer risk in systemic sclerosis
Cohort studySystemic sclerosis
RMD Open20 Sep 2024
Comparative early effectiveness across 14 PsA drugs and 5 classes of PsA treatment: 3-month results from the PRO-SPIRIT study
Cohort studySpondyloarthritis & PsA
RMD Open18 Sep 2024
Attainment of EULAR/ERA-EDTA targets of therapy with current immunosuppressive regimens and adjustments in treatment: a multicentre, real-life observational study
Cohort studyLupus & APS
RMD Open17 Sep 2024
Safety, pharmacokinetics, biomarker response and efficacy of E6742: a dual antagonist of Toll-like receptors 7 and 8, in a first in patient, randomised, double-blind, phase I/II study in systemic lupus erythematosus
Randomized controlled trialLupus & APS
RMD Open17 Sep 2024
Persistence of power Doppler ultrasonography-detected synovitis over 1 year of follow-up predicts poor prognosis in rheumatoid arthritis in clinical remission: the SONORE prospective longitudinal study
Cohort studyRA
RMD Open5 Sep 2024
Inflammatory biomarkers predicting long-term remission and active disease in juvenile idiopathic arthritis: a population-based study of the Nordic JIA cohort
Diagnostic or prognostic studyPediatric
RMD Open5 Sep 2024
Development of a multivariable prediction model for progression of systemic sclerosis-associated interstitial lung disease
Secondary analysisSystemic sclerosis
RMD Open5 Sep 2024
Agreement between patient-reported flares and clinically significant flare status in patients with rheumatoid arthritis in sustained remission: data from the ARCTIC REWIND trials
Diagnostic or prognostic studyRA
RMD Open3 Sep 2024
Comparison of established and preliminarily proposed ASAS MRI working group cut-offs for inflammatory MRI lesions in the sacroiliac joints in radiographic and non-radiographic axial spondyloarthritis
Secondary analysisSpondyloarthritis & PsA
RMD Open29 Aug 2024
Clinical, biological, prognostic characteristics of patients with immune-mediated thrombotic thrombocytopenic purpura and Sjögren’s disease
Cohort studySjögren's & overlap

All 899 Briefs in ExploreShowing Briefs 441–480 of 899, newest first